FEAIX | VIVIX | FEAIX / VIVIX | |
Total Expense Ratio | 0.65 | 0.04 | 1,625% |
Annual Report Gross Expense Ratio | 0.78 | 0.04 | 1,950% |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 15.372 | 8.215 | 187% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 436M | 203B | 0% |
Annual Yield % from dividends | 1.13 | 2.11 | 54% |
Returns for 1 year | 9.61 | 8.08 | 119% |
Returns for 3 years | 45.10 | 37.05 | 122% |
Returns for 5 years | 18.68 | 70.71 | 26% |
Returns for 10 years | -13.41 | 132.36 | -10% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CANC | 27.75 | 0.67 | +2.47% |
Tema Oncology ETF | |||
DBL | 15.64 | N/A | -0.01% |
Doubleline Opportunistic Credit Fund | |||
JCTR | 87.05 | -0.22 | -0.25% |
JPMorgan Carbon Transition US Eq ETF | |||
DTD | 82.46 | -0.44 | -0.53% |
WisdomTree US Total Dividend ETF | |||
HOOG | 60.57 | -1.89 | -3.03% |
Leverage Shares 2X Long HOOD Daily ETF |